日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Effects of Long-Term Treatment with TV-46000 on Symptom Improvement Over Time in Stabilized Patients with Schizophrenia

TV-46000长期治疗对病情稳定的精神分裂症患者症状改善的影响

期刊:CNS Drugs
影响因子:7.4
doi:10.1007/s40263-025-01240-1
Kane, John M; Tohami, Orna; Franzenburg, Kelli R; Suett, Mark; Sharon, Nir; Merenlender-Wagner, Avia; Eshet, Roy; Harary, Eran; Correll, Christoph U
精神分裂症
神经科学
发表日期：2026
文献求助 收藏

Correction: Effects of Long-Term Treatment with TV-46000 on Symptom Improvement Over Time in Stabilized Patients with Schizophrenia

更正：TV-46000长期治疗对病情稳定的精神分裂症患者症状随时间改善的影响

期刊:CNS Drugs
影响因子:7.4
doi:10.1007/s40263-025-01265-6
Kane, John M; Tohami, Orna; Franzenburg, Kelli R; Suett, Mark; Sharon, Nir; Merenlender-Wagner, Avia; Eshet, Roy; Harary, Eran; Correll, Christoph U
精神分裂症
神经科学
发表日期：2026
文献求助 收藏

Safety Outcomes with the Long-Acting Subcutaneous Antipsychotic TV-46000 in Schizophrenia: A Post Hoc Analysis of Behavioral, Neuromotor, Endocrine, and Cardiometabolic Outcomes from Two Phase 3 Studies

长效皮下注射抗精神病药物TV-46000治疗精神分裂症的安全性结果：两项3期研究的行为、神经运动、内分泌和心血管代谢结果的事后分析

期刊:CNS Drugs
影响因子:7.4
doi:10.1007/s40263-025-01197-1
Correll, Christoph U; Knebel, Helena; Harary, Eran; Eshet, Roy; Tohami, Orna; Suett, Mark; Sharon, Nir; Franzenburg, Kelli R; Kane, John M
精神分裂症
神经科学
代谢
发表日期：2025
文献求助 收藏

Population Pharmacokinetic-Based Strategies for Switching Patients with Schizophrenia Between Long-Acting Injectable Formulations of Risperidone: R064766 or RBP-7000 to TV-46000

基于群体药代动力学的利培酮长效注射剂（R064766 或 RBP-7000）与 TV-46000 之间精神分裂症患者转换策略

期刊:Neurology and Therapy
影响因子:4.8
doi:10.1007/s40120-025-00840-9
Perlstein, Itay; Meyer, Jonathan; Kumar, Sharath; Yue, Ziqi; Ivaturi, Vijay; Franzenburg, Kelli R; Suett, Mark; Hansen, Rolf; Merenlender Wagner, Avia; Phatak, Arti; Singh, Rajendra
精神分裂症
神经科学
发表日期：2025
文献求助 收藏

Efficacy and Safety of TV-46000 and Second-Generation Long-Acting Injectable Antipsychotics for Schizophrenia: A Systematic Literature Review and Network Meta-Analysis of Randomized Controlled Trials

TV-46000 和第二代长效注射抗精神病药物治疗精神分裂症的疗效和安全性：随机对照试验的系统文献综述和网络荟萃分析

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-025-03274-9
Franzenburg, Kelli R; Hansen, Rolf; Suett, Mark; Thompson, Stephen F; Sergerie, Martin; Garcia, David; Margolese, Howard C
精神分裂症
神经科学
发表日期：2025
文献求助 收藏

Switching Patients with Schizophrenia from Intramuscular Paliperidone Palmitate Once Monthly to TV-46000, a Long-Acting Subcutaneous Antipsychotic: Population Pharmacokinetic-Based Strategies

将精神分裂症患者从每月一次肌注棕榈酸帕利哌酮转换为长效皮下注射抗精神病药物TV-46000：基于群体药代动力学的策略

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-025-03329-x
Perlstein, Itay; Meyer, Jonathan; Yue, Ziqi; Ivaturi, Vijay; Franzenburg, Kelli R; Suett, Mark; Hansen, Rolf; Merenlender Wagner, Avia; Phatak, Arti; Singh, Rajendra
精神分裂症
神经科学
发表日期：2025
文献求助 收藏

Clinician differences in attitudes and perceptions on the use of long-acting injectable antipsychotic agents in treating patients with schizophrenia: results from the US DECIDE survey

临床医生对使用长效注射抗精神病药物治疗精神分裂症患者的态度和看法存在差异：来自美国DECIDE调查的结果

期刊:BMC Psychiatry
影响因子:3.6
doi:10.1186/s12888-025-06565-1
Velligan, Dawn; Salinas, Gregory D; Belcher, Emily; Franzenburg, Kelli R; Suett, Mark; Thompson, Stephen; Hansen, Rolf T 3rd
精神分裂症
神经科学
IDE
发表日期：2025
文献求助 收藏

Experiences and perceptions of patients, caregivers, and healthcare professionals with long-acting injectable antipsychotics for the treatment of schizophrenia: qualitative results from the multinational ADVANCE study

患者、照护者和医疗保健专业人员对使用长效注射抗精神病药物治疗精神分裂症的体验和看法：来自多国 ADVANCE 研究的定性结果

期刊:Frontiers in Psychiatry
影响因子:3.2
doi:10.3389/fpsyt.2025.1645328
Franzenburg, Kelli R; Hansen, Rolf; Suett, Mark; Yaari, Ayelet; Sergerie, Martin; Peyser Levin, Aviva; Kaplan, Sigal; Gonzalez, Alma; Sedigh, Kameron; Heres, Stephan; Sajatovic, Martha
精神分裂症
神经科学
发表日期：2025
文献求助 收藏

Preferences for Selecting and Initiating Long-Acting Injectable Antipsychotic Agents for the Treatment of Patients With Schizophrenia: Results From the US DECIDE Survey

美国DECIDE调查结果：选择和启动长效注射抗精神病药物治疗精神分裂症患者的偏好

期刊:Schizophrenia Bulletin Open
影响因子:2
doi:10.1093/schizbullopen/sgaf001
Velligan, Dawn; Salinas, Gregory D; Belcher, Emily; Franzenburg, Kelli R; Suett, Mark; Thompson, Stephen; Hansen, Rolf T 3rd
精神分裂症
神经科学
IDE
发表日期：2025
文献求助 收藏

Attitudes Driving Regional Differences in Long-Acting Injectable Antipsychotic Utilization for Schizophrenia among Healthcare Professionals, Patients, and Caregivers (ADVANCE): Results from a Multinational Survey Study

医疗保健专业人员、患者和照护者对长效注射抗精神病药物治疗精神分裂症的态度差异及其区域差异驱动因素（ADVANCE）：一项多国调查研究的结果

期刊:Schizophrenia Bulletin Open
影响因子:2
doi:10.1093/schizbullopen/sgaf032
Franzenburg, Kelli R; Hansen, Rolf; Suett, Mark; Yaari, Ayelet; Peyser Levin, Aviva; Sergerie, Martin; Kaplan, Sigal; Sedigh, Kameron; Heres, Stephan; Sajatovic, Martha
精神分裂症
神经科学
发表日期：2025
文献求助 收藏